Infleqtion and Churchill Capital Corp X Announce Confidential Submission of Draft Registration Statement on Form S-4 in Connection with Proposed Business Combination
BOULDER, Colo. & NEW YORK–(BUSINESS WIRE)–Infleqtion, a global leader in neutral-atom–based quantum technology, and Churchill Capital Corp X (NASDAQ: CCCX), a publicly traded special purpose acquisition company, today announced the confidential submission of a draft registration statement on Form S-4 (the “Registration Statement”) with the U.S. Securities and Exchange Commission (“SEC”) on October 29, 2025. […]